NCT02467322View on ClinicalTrials.gov

To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 23, 2015

Primary Completion Date

December 15, 2016

Study Completion Date

December 15, 2016

Conditions

Decompensated Cirrhosis

Interventions

DRUG

Albumin

MVP of less than 5 liters with iv albumin at a dose 8 gms/L of ascitic fluid.

DRUG

ascitic fluid

Trial Locations (1)

110070

Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02467322 - To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion. | Biotech Hunter | Biotech Hunter